- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05792683
Comparison of Duration of CSF Leak in Post Traumatic Patients Managed by Early Lumbar Drain vs Conservative Treatment
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Atiq UR [arehman], MBBS
- Phone Number: 00923344314213
- Email: drnehria@gmail.com
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 4600
- Recruiting
- RMU
-
Contact:
- Atiq UR rehman, MBBS
- Phone Number: 00923344314213
- Email: drnehria@gmail.com
-
Contact:
- Atiq UR [arehman]
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 15-60 years in both genders.
- Patients with craniospinal post traumatic or post operative CSF leakage for more than 24 hours.
Exclusion Criteria:
- Patients with comorbid like Cardiovascular, Chronic Kidney Disease, Coagulopathies and Pregnancy
- Previous history of chest or abdominal surgery.
- Previous history of any lumbosacral surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Early lumbar drain
30 in this group
|
Patient will be placed in the lateral decubitus position; catheter will be inserted by using a Tuohy needle in the interspinous area of lumbar spine. The LD catheter will reach the lumbar subarachnoid space.The remaining part of the drainage kit will be placed along the back of the patient. The catheter insertion site will be sutured and treated with povidone-iodine ointment. Sterile drape will be used to cover the entire external part of the LD. The CSF will be collected within the closed beg. CSF drainage through LD will be around 10 ml per hour or 200-250 ml/day. |
|
Other: conservative treatment
30 in this group
|
Patient will be placed in the lateral decubitus position; catheter will be inserted by using a Tuohy needle in the interspinous area of lumbar spine. The LD catheter will reach the lumbar subarachnoid space.The remaining part of the drainage kit will be placed along the back of the patient. The catheter insertion site will be sutured and treated with povidone-iodine ointment. Sterile drape will be used to cover the entire external part of the LD. The CSF will be collected within the closed beg. CSF drainage through LD will be around 10 ml per hour or 200-250 ml/day. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of active CSF leak in post-traumatic patients with Lumbar drain.
Time Frame: 06 months
|
Lumbar drain will reduce the CSF pressure on the wound which will lead to early healing of CSF leak sight.it
will reduce the duration of CSF leak in post traumatic patients .
|
06 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of recurrence of CSF leaks, meningitis after treatment
Time Frame: with in 06 months
|
After treatment with both methods the incidence of recurrence of CSF leaks and meningitis will be recorded .
|
with in 06 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Atiq UR [arehman], Rawalpindi Medical College
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEHRIA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.